Leaderboards/Hepatitis B Virus Studies

Hepatitis B Virus Studies

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Jinta Asami
The University of Tokyo
2
Francesco Andreata
Vita-Salute San Raffaele University
3
Yunxuan Feng
Tsinghua University
4
A. Kouakou Viviane
Institut Pasteur de Côte d'Ivoire
5
Elana Ben‐Akiva
Massachusetts Institute of Technology
6
Adriana Palom
Vall d'Hebron Institut de Recerca
7
Alia Ghrayeb
The University of Texas MD Anderson Cancer Center
8
Francesca Ferraresso
University of British Columbia
9
Qianru Li
Hangzhou Medical College
10
Marie‐Anne Meier
University of Basel

Papers

1
Global epidemiology of liver cancer 2022: An emphasis on geographic disparities
Chinese Medical Journal|2024
87 cit.
2
Disparities in 36 cancers across 185 countries: secondary analysis of global cancer statistics
Frontiers of Medicine|2024
80 cit.
3
Serine synthesis via reversed SHMT2 activity drives glycine depletion and acetaminophen hepatotoxicity in MASLD
Cell Metabolism|2024
63 cit.
4
Therapeutic potential of co-signaling receptor modulation in hepatitis B
Cell|2024
39 cit.
5
Structural basis of hepatitis B virus receptor binding
Nature Structural & Molecular Biology|2024
38 cit.
6
Publication in Nature Materials (2025) [36 citations, W4412819448]
Nature Materials|2025
36 cit.
7
CD8 cis-targeted IL-2 drives potent antiviral activity against hepatitis B virus
Science Translational Medicine|2024
26 cit.
8
Protein is expressed in all major organs after intravenous infusion of mRNA-lipid nanoparticles in swine
Molecular Therapy — Methods & Clinical Development|2024
15 cit.
9
Publication in Nature Immunology (2024) [4 citations, W4401960085]
Nature Immunology|2024
4 cit.
10
Gut microbiota-derived 4-hydroxyphenylacetic acid (4-HPAA) inhibits weight gain and is negatively associated with childhood obesity
Translational Pediatrics|2025
4 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Christina Fitzmaurice
Gundersen Health System
2
Paul Bloem
World Health Organization
3
M Ashworth Dirac
Institute for Health Metrics and Evaluation
4
Kathleen Dooling
Pfizer (United States)
5
Rui Huang
Nanjing University of Chinese Medicine
6
John C. Trefry
United States Army Medical Research Institute of Infectious Diseases
7
John Misasi
Boston University
8
Leila Akkari
Oncode Institute
9
NCC National Cancer Center
National Cancer Center
10
Lingyun Dai
Agency for Science, Technology and Research

Papers

1
Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
˜The œLancet. Gastroenterology & hepatology|2022
797 cit.
2
The global, regional, and national burden of benign prostatic hyperplasia in 204 countries and territories from 2000 to 2019: a systematic analysis for the Global Burden of Disease Study 2019
The Lancet Healthy Longevity|2022
250 cit.
3
Use of Recombinant Zoster Vaccine in Immunocompromised Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022
MMWR Morbidity and Mortality Weekly Report|2022
236 cit.
4
Macrophage-mediated myelin recycling fuels brain cancer malignancy
Cell|2024
187 cit.
5
CD103+ regulatory T cells underlie resistance to radio-immunotherapy and impair CD8+ T cell activation in glioblastoma
Nature Cancer|2023
98 cit.
6
Clinical Manifestations of Varicella: Disease Is Largely Forgotten, but It's Not Gone
The Journal of Infectious Diseases|2022
37 cit.
7
Cancer cell genetics shaping of the tumor microenvironment reveals myeloid cell-centric exploitable vulnerabilities in hepatocellular carcinoma
Nature Communications|2024
35 cit.
8
Covid-19 pandemic and equity of global human papillomavirus vaccination: descriptive study of World Health Organization-Unicef vaccination coverage estimates
BMJ Medicine|2024
33 cit.
9
Deep learning enables the discovery of a novel cuproptosis-inducing molecule for the inhibition of hepatocellular carcinoma
Acta Pharmacologica Sinica|2023
28 cit.
10
Changes of Intestinal Microflora in Colorectal Cancer Patients after Surgical Resection and Chemotherapy
Computational and Mathematical Methods in Medicine|2022
17 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Ding‐Shinn Chen
Nanyang Institute of Technology
2
Charles M. Rice
Rockefeller University
3
Michael Houghton
University of Alberta
4
Anna S. Lok
University of Michigan
5
Ralf Bartenschlager
German Cancer Research Center
6
Masashi Mizokami
National Institute of Advanced Industrial Science and Technology
7
Brian J. McMahon
Alaska Native Tribal Health Consortium
8
Robert H. Purcell
National Institutes of Health
9
Harry L.A. Janssen
Erasmus MC
10
Kunitada Shimotohno
National Center for Global Health and Medicine

Papers

1
Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis Genome
Science|1989
6.9k cit.
2
A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis C
Hepatology|2003
4.4k cit.
3
An Assay for Circulating Antibodies to a Major Etiologic Virus of Human Non-A, Non-B Hepatitis
Science|1989
3.4k cit.
4
Chronic hepatitis B
Hepatology|2007
3.1k cit.
5
Chronic hepatitis B: Update 2009 #
Hepatology|2009
2.8k cit.
6
Replication of Subgenomic Hepatitis C Virus RNAs in a Hepatoma Cell Line
Science|1999
2.8k cit.
7
A diverse range of gene products are effectors of the type I interferon antiviral response
Nature|2011
2.5k cit.
8
Complete Replication of Hepatitis C Virus in Cell Culture
Science|2005
2.2k cit.
9
Treatment of HCV Infection by Targeting MicroRNA
New England Journal of Medicine|2013
2.2k cit.
10
Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C
Nature Genetics|2009
2.1k cit.

Reagents for Hepatitis B Virus Studies

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 65

HMGN1 (D1I5O) Rabbit Monoclonal Antibody

Cited in 12 papers
#12734$161,351
View Evidence →
Cell Signaling TechnologyEvidence 68

CD5 Antibody

Cited in 10 papers
#19979$317
View Evidence →
Cell Signaling TechnologyEvidence 63

ALAD (E8Z7Y) Rabbit Monoclonal Antibody

Cited in 10 papers
#76798$161,351
View Evidence →

🌟 All-Time

Most validated

Agilent/Dako

Hepatitis B Virus Core Antigen

Cited in 70 papers
#B0586
View Evidence →
Cell Signaling TechnologyEvidence 65

alpha-Synuclein (E4U2F) Feline Chimeric Monoclonal Antibody

Cited in 34 papers
#79642$161,384
View Evidence →
Cell Signaling Technology

SARS-CoV-2 Spike RBD (multimeric) (319-591) Recombinant Protein (8xHis-Tag)

Cited in 18 papers
#17862$786
View Evidence →